These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2573237)

  • 1. Approaches for finding new types of antipsychotic compounds.
    Sedvall G
    Acta Psychiatr Scand Suppl; 1989; 352():16-23. PubMed ID: 2573237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of dopamine receptors in the mechanism of action of neuroleptics].
    Lavretskaia EF; Kats MM; Baldenkov GN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(3):431-5. PubMed ID: 2859724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New antipsychotic drugs. Pharmacology, therapeutic effect and adverse effects].
    Gerlach J
    Ugeskr Laeger; 1992 Feb; 154(9):548-54. PubMed ID: 1347186
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of remoxipride and some related new substituted salicylamides on rat brain receptors.
    Hall H; Sällemark M; Jerning E
    Acta Pharmacol Toxicol (Copenh); 1986 Jan; 58(1):61-70. PubMed ID: 2869639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic binding to human brain receptors: relation to clinical effects.
    Richelson E
    Ann N Y Acad Sci; 1988; 537():435-42. PubMed ID: 2904784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical findings with new antipsychotic agents: what makes them atypical?
    Jackson DM; Ryan C; Evenden J; Mohell N
    Acta Psychiatr Scand Suppl; 1994; 380():41-8. PubMed ID: 7914047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors.
    Leysen JE; Janssen PM; Schotte A; Luyten WH; Megens AA
    Psychopharmacology (Berl); 1993; 112(1 Suppl):S40-54. PubMed ID: 7530377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological data of the atypical neuroleptic compound melperone (Buronil).
    Christensson EG
    Acta Psychiatr Scand Suppl; 1989; 352():7-15. PubMed ID: 2573242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformationally constrained butyrophenones with affinity for dopamine (D(1), D(2), D(4)) and serotonin (5-HT(2A), 5-HT(2B), 5-HT(2C)) receptors: synthesis of aminomethylbenzo[b]furanones and their evaluation as antipsychotics.
    Raviña E; Casariego I; Masaguer CF; Fontenla JA; Montenegro GY; Rivas ME; Loza MI; Enguix MJ; Villazon M; Cadavid MI; Demontis GC
    J Med Chem; 2000 Nov; 43(24):4678-93. PubMed ID: 11101359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mechanism for the involvement of colocalized neuropeptides in the actions of antipsychotic drugs.
    Gariano RF; Groves PM
    Biol Psychiatry; 1989 Jul; 26(3):303-14. PubMed ID: 2568135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamines and schizophrenia.
    Sedvall G
    Acta Psychiatr Scand Suppl; 1990; 358():7-13. PubMed ID: 1978495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating the neurobiology of schizophrenia. Preface.
    Abi-Dargham A; Guillin O
    Int Rev Neurobiol; 2007; 78():xiii-xvi. PubMed ID: 17349855
    [No Abstract]   [Full Text] [Related]  

  • 13. Dual ligands targeting dopamine D2 and serotonin 5-HT1A receptors as new antipsychotical or anti-Parkinsonian agents.
    Ye N; Song Z; Zhang A
    Curr Med Chem; 2014; 21(4):437-57. PubMed ID: 24164194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors.
    Zhang W; Bymaster FP
    Psychopharmacology (Berl); 1999 Jan; 141(3):267-78. PubMed ID: 10027508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New pharmacological approaches to the treatment of schizophrenia].
    Uzbay IT
    Turk Psikiyatri Derg; 2009; 20(2):175-82. PubMed ID: 19504368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the antipsychotic drug pipamperone on the expression of the dopamine D4 receptor.
    Van Craenenbroeck K; Gellynck E; Lintermans B; Leysen JE; Van Tol HH; Haegeman G; Vanhoenacker P
    Life Sci; 2006 Dec; 80(1):74-81. PubMed ID: 16978659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and atypical antipsychotic profile of some 2-(2-piperidinoethyl)benzocycloalkanones as analogues of butyrophenone.
    Fontenla JA; Osuna J; Rosa E; Castro ME; G-Ferreiro T; Loza-García I; Calleja JM; Sanz F; Rodríguez J; Raviña E
    J Med Chem; 1994 Aug; 37(16):2564-73. PubMed ID: 7914540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular attributes of dopamine receptors: new potential for antipsychotic drug development.
    Hartman DS; Civelli O
    Ann Med; 1996 Jun; 28(3):211-9. PubMed ID: 8811164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency.
    Peroutka SJ; Synder SH
    Am J Psychiatry; 1980 Dec; 137(12):1518-22. PubMed ID: 6108081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical neuroleptics: role of multiple receptors, endogenous dopamine, and receptor linkage.
    Seeman P
    Acta Psychiatr Scand Suppl; 1990; 358():14-20. PubMed ID: 1978482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.